Controversies in respiratory medicine: regular inhaled β-agonists — clearclinical benefit or a hazard to health?: (2) Why β-agonists should not be used regularly

This publication has 23 references indexed in Scilit:

• The Use of β-Agonists and the Risk of Death and near Death from Asthma
  New England Journal of Medicine, 1992
• Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.
  BMJ, 1991
• Asthma mortality and inhaled beta agonist therapy
  Australian and New Zealand Journal of Medicine, 1991
• Asthma—a United Kingdom View; Treatment and Its Implications
  Annals of the New York Academy of Sciences, 1991
• Regular inhaled beta-agonist treatment in bronchial asthma
  The Lancet, 1990
• Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1
  Journal of Allergy and Clinical Immunology, 1990
• REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINE
  The Lancet, 1988
• Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma
  Journal of Allergy and Clinical Immunology, 1987
• Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline
  Journal of Allergy and Clinical Immunology, 1985
• Observations on recent increase in mortality from asthma.
  BMJ, 1968